Product Reports Resources Pricing Login Book a demo

Stemcentrx

Biotech & Life Sciences · South San Francisco, United States · Founded 2008

Develops innovative therapies for cancer

Investors

7 investors on Stemcentrx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

Global footprint

Where Stemcentrx has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Talent graph

The shape of Stemcentrx's talent

Dealroom maps Stemcentrx's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Stemcentrx's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$25M patent portfolio · 19 active families

Estimated portfolio value
$25M
0.25% of valuation · 12.7× smaller than top peer MorphoSys ($321M)
19 active patent families
Where Stemcentrx innovates Anti antibodyAntibody-drug conjugateAntiendomysial antibodiesBiochemistryCancer research

Where Stemcentrx concentrates vs peers

Each axis is a top-10 topic across Stemcentrx and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Stemcentrx

An AI-synthesized read of the highest-engagement posts about Stemcentrx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Stemcentrx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.